HHL-U:CA:TSX-Harvest Healthcare Leaders Income ETF (USD)

ETF | Others |

Last Closing

CAD 8.36

Change

0.00 (0.00)%

Market Cap

N/A

Volume

1.11K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-12-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.10 (+0.38%)

CAD 6.19B
XEQT:CA iShares Core Equity Portfolio

-0.11 (-0.32%)

CAD 5.85B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

N/A

CAD 5.48B
PHYS-U:CA Sprott Physical Gold Trust

N/A

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.28 (-0.74%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

-0.16 (-0.36%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

-0.20 (-0.83%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

-0.10 (-1.01%)

CAD 3.29B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.02 (+0.04%)

CAD 2.98B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.01 (-0.04%)

CAD 2.78B

ETFs Containing HHL-U:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -1.53% 7% C- 19% F
Dividend Return 4.83% 78% C+ 67% D+
Total Return 3.30% 12% F 21% F
Trailing 12 Months  
Capital Gain -1.53% 8% B- 19% F
Dividend Return 4.83% 78% C+ 67% D+
Total Return 3.30% 13% F 21% F
Trailing 5 Years  
Capital Gain 1.09% 34% F 41% F
Dividend Return 39.50% 94% A 93% A
Total Return 40.59% 58% F 56% F
Average Annual (5 Year Horizon)  
Capital Gain 3.62% 55% F 47% F
Dividend Return 4.20% 55% F 43% F
Total Return 0.58% 85% B 35% F
Risk Return Profile  
Volatility (Standard Deviation) 7.35% 66% D+ 83% B
Risk Adjusted Return 57.16% 74% C 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike